MGMT and central nervous system cancer: The probability of the high‐risk group in MGMT promoter unmethylation gliomas was also significantly higher compared to methylation gliomas (Figure S6C), which is consistent with previous conclusions (Figure 4A), indicating the accuracy of the SVM‐based subtyping of the TCGA cohort.